12:46 PM
Nov 06, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Liver cancer

In silico, in vitro, cell culture and mouse studies identified a positive allosteric modulator (PAM) of SIRT6 that could help treat hepatocellular carcinoma (HCC). In silico screening of a small molecule library for compounds predicted to bind an allosteric...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >